Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer

NCT03112590 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Breast Cancer, Male
Breast Cancer Female
HER2-positive Breast Cancer

Interventions

BIOLOGICAL: Interferon-gamma (IFN-γ)
DRUG: Paclitaxel
DRUG: Trastuzumab
OTHER: Pertuzumab
PROCEDURE: Post Therapy Surgery

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]